Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Input: Consider Input: Novacyt said the FDA’s approval meant that hospitals and laboratories in the United States would be able to use the test for clinical diagnosis of the coronavirus, and that the test was now available for immediate distribution in the U.S. market. “The U.S. FDA EUA authorization is another important endorsement of the performance and quality of our COVID-19 test and demonstrates once again Novacyt’s growing role in tackling this pandemic,” said Novacyt CEO Graham Mullis.

Output: Healthcare group Novacyt wins U.S. approval for coronavirus test.


Input: Consider Input: Eighteen people who became ill attended the private function Nov. 24 at the Puritan Backroom conference center in Manchester, the state Department of Health and Human Services said. The person who later died was an adult from Hillsborough County. No other details were issued about the person, in accordance with federal and state privacy laws. The state medical examiner’s office completed its final report Tuesday after conducting an autopsy last month. The restaurant is co-owned by U.S. Rep. Chris Pappas. It has been in his family for more than a century and is a frequent stop for presidential candidates of both parties. The manager of the Puritan Backroom said recently that the restaurant’s top priorities are promoting health and excellent food safety and that he was confident it was doing everything possible to maintain those practices. After the outbreak, the Manchester Health Department conducted an inspection of the restaurant. Officials determined there was no ongoing norovirus risk to the public. Symptoms include diarrhea, vomiting, nausea and stomach pain.

Output: Officials: Norovirus contributed to restaurant patron death.


Input: Consider Input: The significant costs of both drugs were mentioned. Nice job. Good job describing the benefits reported in the two drug studies. The two papers present a bewildering array of statistics. This story did a nice job distilling the information into a couple of very understandable sentences. Good job explaining signifcant potential harms of both drugs – something competitors didn’t do at all. Nice job, including linking (in the online version) to the papers in the New England Journal of Medicine. No disease-mongering of melanoma. Several independent sources cited. The story adequately explained the comparisons between both new drugs and the older dacarbazine chemo drug. Vemurafenib was described as experimental and as “expected to be approved by the FDA within a few months.”  Ipilimumab was explained to be approved in March and already on the market. The relative novelty of both drugs was well explained. It’s clear that the story did not rely on a news release.


Output: Drugs Show Promise Slowing Advanced Melanoma